-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Cardinal Health, Raises Price Target to $280

Benzinga·08/12/2026 13:13:10
Listen to the news
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $274 to $280.